Motivational Interviewing for Alcohol Use Disorder: A Comprehensive Clinical and Research Review

Overview

Motivational Interviewing (MI) is a collaborative, person-centered counseling style designed to help people resolve ambivalence about behavior change. It is not a pep talk, a lecture, or a checklist. MI has a defined structure, measurable techniques, and a growing research base that spans primary care clinics, addiction treatment programs, emergency departments, and digital health platforms.

For alcohol use disorder (AUD) specifically, MI is the most studied brief behavioral intervention in the world. Dozens of randomized controlled trials and multiple Cochrane-level meta-analyses have examined its effects. The evidence is real — and it is also more nuanced than popular summaries suggest. Effect sizes are modest. MI performs similarly to other active treatments when those treatments are competently delivered. Fidelity to the MI model matters, though the precise relationship between fidelity and outcomes remains an open scientific question.

This article synthesizes findings from a multi-expert panel — including a clinical psychologist, a primary care physician, an addiction medicine physician, a person in long-term recovery, and a health services researcher — to provide the most complete, honest, and clinically useful account of MI for AUD currently supported by the evidence.

Foundations — Miller and Rollnick

MI was developed by William Miller in 1983, initially as a response to the confrontational approaches that dominated AUD treatment at the time. The prevailing model held that people with alcohol problems needed to be broken down — their denial challenged, their defenses stripped away — before they could accept help. Miller's clinical observations, and the research that followed, pointed in the opposite direction: confrontation increased resistance, while empathic listening opened doors.

Refined in collaboration with Stephen Rollnick, MI is now defined by four core elements of spirit: collaboration (the clinician and client work as partners, not expert and patient), evocation (the clinician draws out the client's own reasons for change rather than imposing them), autonomy (the client's right to make their own decisions is explicitly honored), and compassion (the clinician acts in the client's genuine interest). A fifth element, acceptance, was added in later editions of the foundational text.

These are not soft values. They are operationally defined, trainable, and measurable. The distinction between MI and "being supportive" is the same as the distinction between surgery and "being careful with a knife." MI has structure. That structure can be assessed, coded, and — when absent — identified as a source of harm.

Core Techniques — OARS

The four foundational MI skills are grouped under the acronym OARS:

• Open questions invite the client to explore their own thoughts and feelings rather than answering yes or no. "What concerns you most about your drinking?" opens a conversation. "Do you drink too much?" closes it.

• Affirmations recognize the client's strengths, efforts, and values — not as flattery, but as genuine acknowledgment. "You've kept showing up even when it's been hard" is an affirmation. "Good job" is not.

• Reflective listening is the technical heart of MI. A simple reflection mirrors back what the client said. A complex reflection goes further — it captures the emotion beneath the words, or the meaning the client hasn't quite said yet. Complex reflections are harder to learn and more powerful when done well.

• Summaries pull together what the client has said across a conversation, often emphasizing change talk and linking it to the client's own stated values. A well-constructed summary can shift the entire direction of a session.

These skills are not decorative. Magill et al.'s meta-analysis of MI's causal model found that therapist MI-consistent skills — which include OARS — were significantly correlated with client change talk (r = .26, p < .0001), while MI-inconsistent behaviors were associated with less change talk (r = -.17, p = .001) and more sustain talk (r = .07, p = .009) ^[1]. The techniques produce measurable effects on what clients say — and what clients say predicts what they do.

Change Talk vs. Sustain Talk

One of MI's most important contributions to clinical science is the distinction between change talk and sustain talk.

Change talk refers to client statements that favor change. These fall into several categories: desire ("I want to cut back"), ability ("I think I could do it"), reasons ("My liver results scared me"), need ("I have to do something"), and commitment ("I'm going to try"). The presence of change talk in a session is a signal that the client is moving toward action.

Sustain talk refers to client statements that favor the status quo: "I don't really have a problem," "I enjoy drinking," "I don't think medication would help me." Sustain talk is not the same as lying or denial — it is the normal voice of ambivalence, and every person considering a significant behavior change experiences it.

The clinical significance of this distinction is asymmetric and important. Magill et al. found that while change talk showed only a weak and non-significant relationship with outcomes (r = .06, p = .41), sustain talk was a significantly stronger predictor of worse outcomes (r = -.24, p = .001) ^[1]. A follow-up analysis refined this further: sustain talk subtypes around reason, desire, and ability were each independently associated with more addictive behavior at follow-up ^[2].

The clinical implication is counterintuitive: avoiding the wrong moves may matter more than making the right ones. A clinician who generates enthusiasm for change but also triggers defensive sustain talk may produce worse outcomes than one who simply does not push. This finding reframes MI training — the goal is not only to elicit change talk, but to create conditions in which sustain talk does not escalate.

Rolling with Resistance

When a client argues for the status quo, MI does not counter-argue. This is one of the sharpest contrasts between MI and the confrontational approaches it replaced.

The MI response to resistance — now more precisely called discord or sustain talk in contemporary MI — is to reflect, reframe, or shift focus. If a client says "I don't think I drink that much," an MI-consistent response might be: "You're not sure the amount is really the issue." This is a simple reflection that neither agrees nor disagrees, but keeps the conversation open. A complex reflection might add: "And at the same time, something brought you here today." This acknowledges the ambivalence without pushing.

What MI does not do is lecture, warn, or argue. Berry et al.'s therapist focus group identified a theme they called "talking the talk versus walking the walk" — the gap between practitioners who could perform MI techniques and those who genuinely embodied the spirit ^[3]. From the perspective of people receiving MI, that gap is immediately perceptible. A practitioner running a protocol produces a different experience than one who is genuinely curious about the client's perspective.

The confrontational alternative — sometimes called "tough love" — has not been shown to outperform MI and has been associated with increased resistance. The evidence base does not support it for AUD.

Trial Evidence

The Cochrane Evidence Base

The most comprehensive recent synthesis is the Cochrane review by Schwenker et al., which included 93 RCTs and 22,776 participants ^[4]. Compared to no intervention, MI showed a small-to-moderate effect on substance use post-intervention (SMD 0.48, 95% CI 0.07–0.89), weakening at short-term follow-up (SMD 0.20, 95% CI 0.12–0.28) and further at medium-term (SMD 0.12) ^[4]. Certainty of evidence was low to very low throughout.

The finding that demands clinical attention is the active comparator result: compared to other active interventions, MI showed no significant difference at any follow-up time point — post-intervention (SMD 0.07, 95% CI -0.15 to 0.29), short-term (SMD 0.05), medium-term (SMD 0.08), or long-term (SMD 0.03) ^[4]. The one exception: compared specifically to assessment and feedback, MI showed a moderate-certainty benefit at medium- and long-term follow-up (SMD 0.24 at both time points).

This finding does not mean MI is ineffective. It means MI is roughly equivalent to other competently delivered active treatments — which has direct implications for clinical decision-making. The question is not "MI versus nothing" but "MI versus what, delivered by whom, with what infrastructure."

Earlier Meta-Analyses

Burke et al. reported moderate effect sizes (d = 0.25–0.57) versus no treatment or placebo, with a 56% reduction in client drinking and 51% improvement rates across AMI (Adapted Motivational Interviewing) studies ^[5]. Vasilaki et al. found an aggregate effect size of 0.18 (95% CI 0.07–0.29) for brief MI versus no treatment, noting that efficacy increased when dependent drinkers were excluded ^[6]. Smedslund et al. found the strongest effects post-intervention (SMD 0.79 vs. no treatment), decaying to non-significance at long-term follow-up ^[7].

Young Adults

For young adults specifically, the 2016 Cochrane review (84 trials, 22,872 participants) found statistically significant but clinically small effects at four or more months of follow-up: quantity reduction (SMD -0.11), frequency reduction (SMD -0.14), and peak blood alcohol concentration reduction (SMD -0.12) ^[8]. The authors concluded these effects were "too small to be of relevance to policy or practice" — a sobering assessment that the panel noted should not be dismissed ^[8].

Project MATCH

Project MATCH, one of the largest psychotherapy trials ever conducted for AUD, compared Motivational Enhancement Therapy (MET — a four-session MI-based intervention) to Cognitive Behavioral Therapy (CBT) and Twelve-Step Facilitation (TSF). MET produced outcomes roughly equivalent to the longer CBT and TSF protocols, despite requiring fewer sessions. This finding established MI-based approaches as clinically credible and cost-efficient, though it also reinforced the pattern of equivalence across active treatments that the Schwenker review later confirmed at scale ^[4].

Brief MI in Primary Care

Most people with AUD first encounter the health system not in a specialty addiction clinic but in a primary care office. This makes brief MI — delivered in one to three sessions, often by a physician or nurse — a critical public health tool.

The Rubak et al. systematic review found that brief MI encounters of 15 minutes showed an effect in 64% of studies, and that physicians specifically obtained effects in approximately 80% of studies ^[9]. Importantly, more than one encounter improved effectiveness — a finding that maps well onto how primary care actually functions through longitudinal relationships rather than single visits.

Miller et al. found that the majority of primary care patients support physician screening for alcohol use and are open to advice ^[10]. The concern that patients will be offended by alcohol screening is largely unsupported by evidence.

Brief MI is the behavioral core of SBIRT — Screening, Brief Intervention, and Referral to Treatment — the framework endorsed for primary care integration. Satre et al.'s RCT in HIV-positive primary care patients found that even treatment-as-usual SBIRT produced significant reductions in unhealthy alcohol use, with MI adding particular benefit for patients with low motivation at baseline (p = 0.013) ^[11]. This is a clinically important moderator: MI may add the most value precisely for the patients who seem least ready to change.

Witkiewitz et al. make a compelling case for framing success in terms of WHO Risk Drinking Level reductions rather than abstinence ^[12]. A two-level reduction in WHO risk category is associated with meaningful health improvements and is a far more achievable goal to discuss in a 15-minute visit than complete abstinence. This reframes what "successful" brief MI looks like in primary care.

MI and Pharmacotherapy

Medications for AUD — including naltrexone, acamprosate, and disulfiram — are underutilized relative to their evidence base. One barrier is patient ambivalence about taking medication for a condition many people still understand in moral rather than medical terms.

MI techniques are directly applicable to the prescribing conversation. The ask-tell-ask framework — asking what the patient already knows, providing information, then asking what they make of it — is an MI-consistent approach to medication discussion that respects autonomy and reduces the risk of triggering sustain talk. Kisely et al. demonstrated a direct translational model, applying OARS techniques to the initiation of long-acting injectable antipsychotics in psychiatric patients ^[13]. While this addresses antipsychotics rather than AUD medications specifically, the clinical logic transfers: MI techniques can structure the conversation around medication ambivalence in ways that reduce resistance rather than amplify it.

The mechanism evidence from Magill et al. is particularly relevant here ^[1]. When a patient says "I don't think I really need medication," that is not merely ambivalence to tolerate — it is sustain talk with a documented association with worse outcomes. The MI-trained prescriber's goal is not to generate enthusiasm for naltrexone but to create conditions in which the patient's own reasons for considering medication can emerge.

Critical gap: The corpus contains no RCTs examining MI as a lead-in specifically to pharmacotherapy initiation for AUD. The evidence for MI facilitating MAT uptake or adherence is inferential, not direct. This is a significant research gap.

Fidelity Assessment

MI delivered with fidelity is not the same as MI delivered in name only. The difference matters — though the precise relationship between fidelity and outcomes is more complicated than the field initially assumed.

The Motivational Interviewing Treatment Integrity (MITI) scale is the current gold-standard instrument for coding MI fidelity. It assesses therapist behaviors across dimensions including reflections-to-questions ratio, percentage of complex reflections, and MI-consistent versus MI-inconsistent behaviors. The MIA-STEP coding system provides an alternative framework for session-level assessment.

Kramer Schmidt et al. examined MITI 4 fidelity across 423 coded sessions in an RCT of older adults with AUD and found that none of the MI fidelity predictors were associated with treatment outcomes at 26-week follow-up ^[14]. This is a striking finding. The authors offer an important qualification: MI may be less effective in populations already committed to change, and the study population was treatment-seeking older adults — a group with higher baseline motivation than many clinical populations.

The mechanistic evidence from Magill et al. offers a partial counterpoint ^[1]: therapist MI-consistent skills do shape the session process in measurable ways, correlating with more client change talk and less sustain talk. If sustain talk predicts worse outcomes, then fidelity may matter through a pathway that outcome studies have not yet adequately captured.

The honest synthesis: fidelity shapes the process of MI in documented ways, but whether that process reliably translates to better outcomes — across populations, settings, and treatment combinations — remains an open question. Lindson-Hawley et al. noted that "critical details in how it was modified... the training of therapists and the content of the counselling were sometimes lacking from trial reports" ^[15], a methodological gap that limits confidence across the entire literature.

Therapist Training and Workforce

MI requires more than a one-day workshop. One-day trainings produce surface-level familiarity with MI vocabulary but not the sustained competence that fidelity-coded delivery requires. The research consistently shows that skill acquisition requires ongoing coaching, feedback, and practice — not a single training event.

Kramer Schmidt et al. found that fidelity scores were lower when MI was combined with other treatment approaches than in pure MET sessions ^[14]. This is a direct signal that workforce training in integrated delivery is inadequate — practitioners who can deliver MI in isolation may lose fidelity when asked to combine it with CBT, case management, or medication counseling.

Berry et al.'s therapist focus group identified the theme of "talking the talk versus walking the walk" — the gap between practitioners who could perform MI techniques and those who genuinely embodied the MI spirit ^[3]. This distinction is not merely philosophical. From the perspective of people receiving MI, it is immediately perceptible and clinically consequential.

The workforce implications are significant. Systems that invest in MI training without investing in ongoing supervision, fidelity monitoring, and coaching are likely producing a diluted version of the intervention — one that may explain why real-world effect sizes are smaller than those in controlled trials.

Telehealth and Digital MI

The Possemato et al. PC-TIME trial delivered five brief MI sessions in a primary care-embedded model and demonstrated significant reductions in heavy drinking ^[16], providing evidence that structured brief MI can be delivered effectively in non-specialty settings.

Riper et al. found that digital CBT/MI interventions for comorbid AUD and depression showed a notably higher effect size for depression in digital versus face-to-face delivery (g = 0.73 vs. 0.23, p = 0.030) ^[17]. This is a striking finding that raises the possibility that digital platforms may approximate MI's relational mechanisms at lower workforce cost — though the available evidence does not yet address whether digital delivery maintains fidelity to MI's technical components.

Automated and chatbot-based MI approaches are under active investigation. Evidence remains mixed, and the corpus does not contain documents sufficient to draw firm conclusions about their efficacy relative to human-delivered MI.

Special Populations

Comorbid Mental Health Conditions

MI has been studied in populations with co-occurring AUD and depression ^[17], PTSD ^[16], and anxiety ^[18]. Combined CBT/MI for comorbid AUD and depression showed small but significant effects (g = 0.17 for alcohol outcomes, g = 0.27 for depression) ^[17]. Bastos-Maia et al. examined MI outcomes and challenges in dual diagnosis populations more broadly ^[19].

Culturally Adapted MI

Lee et al.'s RCT of 296 Latinx heavy drinkers found that both standard and culturally adapted MI (CAMI) produced significant drinking reductions, but acculturation level and discrimination exposure moderated treatment response: less acculturated individuals and those experiencing higher discrimination showed significantly better outcomes with CAMI versus standard MI at three months (d = .34 and d = .20, respectively) ^[20]. This is direct evidence that cultural adaptation is not merely cosmetic — it produces measurable differential benefit for specific subgroups.

Adolescents and College Students

The Foxcroft Cochrane review included substantial data from young adult and college populations ^[8]. Effects were statistically significant but clinically small. Developmental adaptation of MI for adolescents — including attention to autonomy, peer influence, and identity — is supported by clinical consensus, though the corpus does not contain documents specifically addressing adolescent-adapted MI protocols.

Pregnant Women

The corpus does not contain documents specifically addressing MI for AUD in pregnant women. This is a significant gap given the clinical importance of alcohol reduction in pregnancy.

Veterans

Possemato et al.'s PC-TIME trial was conducted in a VA primary care setting ^[16], providing some evidence for MI in veteran populations with comorbid PTSD and AUD.

Evidence Gaps

The panel identified several areas where the current corpus — and the broader literature — cannot yet provide confident answers:

Mechanism research. The technical hypothesis — that change talk mediates MI's effects — receives only partial support. Sustain talk predicts worse outcomes more reliably than change talk predicts better ones ^[1]. The precise causal pathway through which MI produces its effects remains incompletely understood, and further mechanistic research is needed.

Long-term outcomes. Most trials follow participants for six to twelve months ^[4]. The corpus contains little data on whether MI's effects persist beyond one year, or whether booster sessions are needed to maintain gains.

Fidelity in real-world community settings. The corpus cannot answer what happens to MI's effect sizes when delivered by community health workers or primary care staff trained in brief workshops — the actual workforce delivering SBIRT at scale ^[14]. The study combining implementation fidelity measurement with population-level outcomes and cost data has not yet been done.

MI as a lead-in to pharmacotherapy. The corpus contains no RCTs examining MI specifically as a bridge to naltrexone, acamprosate, or disulfiram initiation for AUD. The clinical logic is sound; the direct evidence is absent.

Qualitative recovery research. The corpus contains almost no qualitative data from people in recovery about what the MI interaction felt like — whether it felt genuine or scripted, whether it produced shame or curiosity, whether it opened a door or closed one. Gaume et al.'s iterative design study used semi-structured interviews with patients to refine an intervention model ^[21], but that addresses feasibility rather than lived experience of the mechanism. This is a meaningful gap in a field that claims to be person-centered.

Training dosage and skill decay. The corpus does not describe training program structures, hours required, competency assessment protocols, or how fidelity degrades over time without ongoing supervision ^[15]. These are foundational workforce questions that the evidence base cannot yet answer.

Clinical Takeaways

Drawing across all five expert perspectives, the following evidence-supported conclusions anchor clinical practice:

1. MI outperforms no intervention with small-to-moderate effect sizes, but performs roughly equivalently to other competently delivered active treatments ^[4]. The clinical question is not "MI versus nothing" but "MI versus what, for whom."

2. Baseline motivation is the most actionable moderator. MI adds the most value for patients with low motivation to change ^[11]. For already-motivated patients, simpler interventions may suffice ^[14].

3. Avoiding MI-inconsistent behaviors may matter more than perfecting MI-consistent ones. Sustain talk predicts worse outcomes more reliably than change talk predicts better ones ^[1]. Confrontational, coercive, or formulaic delivery does not merely fail to help — it may actively harm.

4. Brief MI works in primary care, but repeated contact improves outcomes. A single 15-minute encounter has real but limited impact; the model that works is repeated brief contacts over time ^[9].

5. Cultural adaptation produces measurable differential benefit for specific subgroups and should not be treated as optional for diverse populations ^[20].

6. Fidelity matters, but the fidelity-outcome link is not yet established in routine care. Systems that invest in MI training without ongoing supervision and fidelity monitoring are likely delivering a diluted version of the intervention ^{[14] [15]}.

7. Drinking reduction — not only abstinence — is a clinically meaningful goal. WHO Risk Drinking Level reductions are associated with improved health outcomes and represent a more achievable and honest target for many patients ^[12].

MI is not a cure. It is a specific, structured, evidence-based approach to one of the hardest problems in clinical medicine: helping a person who is ambivalent about change find their own reasons to move. When delivered with genuine fidelity and genuine care, it opens doors that other approaches close. The evidence supports using it — carefully, skillfully, and with honest expectations about what it can and cannot do.

Verified References

• ^[19] Bastos Maia, Margarida, Martins, Pedro Miguel, Figueiredo-Braga, Margarida (2025). "Outcomes and Challenges of Motivational Interviewing in Dual Diagnosis Treatment-A Systematic Review.". J Dual Diagn. DOI: 10.1080/15504263.2024.2434218 [abstract-verified: yes]
• ^[3] Berry, Katherine, Barrowclough, Christine, Fitsimmons, Mike et al. (2020). "Overcoming challenges in delivering integrated motivational interviewing and cognitive behavioural therapy for bipolar disorder with co-morbid alcohol use: therapist perspectives.". Behav Cogn Psychother. DOI: 10.1017/s1352465820000272 [abstract-verified: partial]
• ^[18] Buckner, Julia D (2024). "Motivational interviewing-based interventions with patients with comorbid anxiety and substance use disorders.". Curr Opin Psychol. DOI: 10.1016/j.copsyc.2024.101934 [abstract-verified: partial]
• ^[5] Burke, Brian L, Arkowitz, Hal, Menchola, Marisa (2003). "The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials.". J Consult Clin Psychol. DOI: 10.1037/0022-006x.71.5.843 [abstract-verified: yes]
• ^[8] Foxcroft, David R, Coombes, Lindsey, Wood, Sarah et al. (2016). "Motivational interviewing for the prevention of alcohol misuse in young adults.". Cochrane Database Syst Rev. DOI: 10.1002/14651858.cd007025.pub4 [abstract-verified: yes]
• ^[21] Gaume, Jacques, Grazioli, Véronique S, Paroz, Sophie et al. (2021). "Developing a brief motivational intervention for young adults admitted with alcohol intoxication in the emergency department - Results from an iterative qualitative design.". PLoS One. DOI: 10.1371/journal.pone.0246652 [abstract-verified: partial]
• ^[13] Kisely, Steve, Ligate, Loys, Roy, Marc-André et al. (2012). "Applying Motivational Interviewing to the initiation of long-acting injectable atypical antipsychotics.". Australas Psychiatry. DOI: 10.1177/1039856212437257 [abstract-verified: yes]
• ^[14] Kramer Schmidt, Lotte, Moyers, Theresa B, Nielsen, Anette Søgaard et al. (2019). "Is fidelity to motivational interviewing associated with alcohol outcomes in treatment-seeking 60+ year-old citizens?". J Subst Abuse Treat. DOI: 10.1016/j.jsat.2019.03.004 [abstract-verified: yes]
• ^[20] Lee, Christina S, Colby, Suzanne M, Rohsenow, Damaris J et al. (2019). "A randomized controlled trial of motivational interviewing tailored for heavy drinking latinxs.". J Consult Clin Psychol. DOI: 10.1037/ccp0000428 [abstract-verified: partial]
• ^[15] Lindson-Hawley, Nicola, Thompson, Tom P, Begh, Rachna (2015). "Motivational interviewing for smoking cessation.". Cochrane Database Syst Rev. DOI: 10.1002/14651858.cd006936.pub3 [abstract-verified: yes]
• ^[1] Magill, Molly, Gaume, Jacques, Apodaca, Timothy R et al. (2014). "The technical hypothesis of motivational interviewing: a meta-analysis of MI's key causal model.". J Consult Clin Psychol. DOI: 10.1037/a0036833 [abstract-verified: partial]
• ^[2] Magill, Molly, Bernstein, Michael H, Hoadley, Ariel et al. (2019). "Do what you say and say what you are going to do: A preliminary meta-analysis of client change and sustain talk subtypes in motivational interviewing.". Psychother Res. DOI: 10.1080/10503307.2018.1490973 [abstract-verified: partial]
• ^[10] Miller, Peter M, Thomas, Suzanne E, Mallin, Robert (2006). "Patient attitudes towards self-report and biomarker alcohol screening by primary care physicians.". Alcohol Alcohol. DOI: 10.1093/alcalc/agl022 [abstract-verified: yes]
• ^[16] Possemato, Kyle, Mastroleo, Nadine R, Balderrama-Durbin, Christina et al. (2024). "A Randomized Controlled Pilot Trial of Primary Care Treatment Integrating Motivation and Exposure Treatment (PC-TIME) in Veterans With PTSD and Harmful Alcohol Use.". Behav Ther. DOI: 10.1016/j.beth.2023.08.011 [abstract-verified: partial]
• ^[17] Heleen Riper, Gerhard Andersson, Sarah B Hunter et al. (2014). "Treatment of comorbid alcohol use disorders and depression with cognitive-behavioural therapy and motivational interviewing: a meta-analysis.". Addiction (Abingdon, England). DOI: 10.1111/add.12441 [abstract-verified: yes]
• ^[9] Sune Rubak, Annelli Sandbaek, Torsten Lauritzen et al. (2005). "Motivational interviewing: a systematic review and meta-analysis.". The British journal of general practice : the journal of the Royal College of General Practitioners. [abstract-verified: partial]
• ^[11] Satre, Derek D, Leibowitz, Amy S, Leyden, Wendy et al. (2019). "Interventions to Reduce Unhealthy Alcohol Use among Primary Care Patients with HIV: the Health and Motivation Randomized Clinical Trial.". J Gen Intern Med. DOI: 10.1007/s11606-019-05065-9 [abstract-verified: yes]
• ^[4] Schwenker, Rosemarie, Dietrich, Carla Emilia, Hirpa, Selamawit et al. (2023). "Motivational interviewing for substance use reduction.". Cochrane Database Syst Rev. DOI: 10.1002/14651858.cd008063.pub3 [abstract-verified: yes]
• ^[7] Smedslund, Geir, Berg, Rigmor C, Hammerstrøm, Karianne T et al. (2011). "Motivational interviewing for substance abuse.". Cochrane Database Syst Rev. DOI: 10.1002/14651858.cd008063.pub2 [abstract-verified: yes]
• ^[6] Vasilaki, Eirini I, Hosier, Steven G, Cox, W Miles (2006). "The efficacy of motivational interviewing as a brief intervention for excessive drinking: a meta-analytic review.". Alcohol Alcohol. DOI: 10.1093/alcalc/agl016 [abstract-verified: yes]
• ^[12] Witkiewitz, Katie, Anton, Raymond F, O'Malley, Stephanie S et al. (2025). "Reductions in World Health Organization Risk Drinking Levels as a Primary Efficacy End Point for Alcohol Clinical Trials: A Review.". JAMA Psychiatry. DOI: 10.1001/jamapsychiatry.2025.2508 [abstract-verified: yes]

Replacement Resolution Audit

Each REPLACE verdict from the adjudication pass was resolved by re-querying the indexed fulltext corpus and selecting the highest-scoring paper that the Level 3 verifier confirmed supports the claim.

• ^[2] → NO REPLACEMENT FOUND (considered 4 candidates; none verified)
• ^[2] → ^[1] (verifier: partial; score 0.70). Title: Does readiness to change predict in-session motivational language? Correspondence between two conceptualizations of clie
• ^[8] → ^[20] (verifier: partial; score 0.81). Title: Clinical interventions for adults with comorbid alcohol use and depressive disorders: A systematic review and network me
• ^[2] → ^[22] (verifier: partial; score 0.68). Title: _Technical and relational process in MI sessions with a sample of Hispanic/Latinx adults who engage in heavy drinking: A _
• ^[23] → ^[2] (verifier: partial; score 0.62). Title: The technical hypothesis of motivational interviewing: a meta-analysis of MI's key causal model.
• ^[24] → NO REPLACEMENT FOUND (considered 3 candidates; none verified)
• ^[24] → ^[3] (verifier: partial; score 0.58). Title: Implementation Factors Influencing Peer-Delivered Behavioral Evidence-Based Interventions for Substance Use Disorders: A
• ^[25] → ^[8] (verifier: partial; score 0.80). Title: A randomized controlled trial of motivational interviewing tailored for heavy drinking latinxs.
• ^[26] → ^[9] (verifier: partial; score 0.63). Title: Treatment of substance abusing patients with comorbid psychiatric disorders.
• ^[26] → ^[27] (verifier: partial; score 0.66). Title: A qualitative interview study of patient experiences of receiving motivational enhancement therapy in a Swedish addictio
• ^[14] → NO REPLACEMENT FOUND (considered 5 candidates; none verified)
• ^[15] → NO REPLACEMENT FOUND (considered 5 candidates; none verified)
• ^[16] → NO REPLACEMENT FOUND (considered 3 candidates; none verified)